Merida Biosciences

Biotech · Cambridge, MA · Founded 2022 · Privately Held (backing)

Developer of targeted immunotherapies designed for the treatment of autoimmune and allergic diseases. Merida Biosciences is based in Cambridge, MA and was founded in 2022. It was valued at $228 million at its early-stage round in Apr 2025, the last priced event on record. It has raised $154 million across 1 recorded round; the latest was a $121 million Series A in Apr 2025.

PMV mark · valuation
$228.0M
Oct 2026
Priced at
its early-stage round
Apr 2025
Total raised
$154.0M
Last round
Series A
Apr 2025

Who backs Merida Biosciences?

6 investors
InvestorType
GVVenture capital
The EngineOther
Perceptive AdvisorsHedge fund
Bain Capital Life SciencesVenture capital
Third Rock VenturesVenture capital
BVF Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Merida Biosciences investors

6 investors are on record for Merida Biosciences, including GV, The Engine, Perceptive Advisors and Bain Capital Life Sciences.

Free account
More of Merida Biosciences with a free account
  • ·Everyone on the team, board and advisors included
  • ·Watch Merida Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like Merida Biosciences in biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View